Experiment 635150

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismSilybum marianum (ASTERACEAE)
CitationPEPPING,J:. (1999). MILK THISTLE: SILYBUM MARIANUM.. 56(12)
Amount utilized
Compound isolated
DiseaseDOUBLE-BLIND STUDIES IN PATIENTS WITH ACUTE VIRAL HEPATITIS GENERALLY SUGGEST THAT THERAPY WITH SILYMARIN DECREASES COMPLICATIONS, HASTENS RECOVERY, AND SHORTENS HOSPITALIZATION. IN A STUDY BY MAGLIULO ET AL., 57 PATIENTS WITH ACUTE HEPATITIS A OR B WERE RANDOMIZED TO RECEIVE 140 MG OF SILYMARIN 3X A DAY FOR AT LEAST THREE WEEKS OF PLACEBO. UNDERLYING LIVER DISEASE AND ALCOHOL USE WERE NOT ADDRESSED IN THE STUDY. THE MEAN DURATION OF THERAPY WAS 26.6 DAYS. THE PERCENTAGE OF PATIENTS WITH NORMALIZATION OF ASPARTATE TRANSAMINASE (AST) CONCENTRATION WITHIN 3 WEEKS WAS 82% IN THE TREATMENT GROUP, VERSUS 52% IN THE CONTROL GROUP. THE PERCENTAGE WITH NORMALIZED TOTAL BILIRUBIN WAS 40% IN THE TREATMENT GROUP AND 11% AMONG THE CONTROLS.
Dose amount420.0 MG
Number7
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHYDRO-ALCOHOLIC EXT